510 related articles for article (PubMed ID: 1370261)
1. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
2. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
[TBL] [Abstract][Full Text] [Related]
3. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas.
Scarpino S; Di Napoli A; Stoppacciaro A; Antonelli M; Pilozzi E; Chiarle R; Palestro G; Marino M; Facciolo F; Rendina EA; Webster KE; Kinkel SA; Scott HS; Ruco L
Clin Exp Immunol; 2007 Sep; 149(3):504-12. PubMed ID: 17590173
[TBL] [Abstract][Full Text] [Related]
4. Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.
Radrizzani M; Quaia M; Benedetti B; Andreola S; Vaglini M; Galligioni E; Fossati G; Parmiani G
Cancer Immunol Immunother; 1989; 30(4):233-8. PubMed ID: 2574630
[TBL] [Abstract][Full Text] [Related]
5. Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression.
Furuya T; Ishihara S; Ogi H; Masuda K; Shibata S; Nakazono C; Okada S; Shimomura M; Tando S; Yaoi T; Maeda Y; Yamagishi M; Kawamoto H; Itoh K; Inoue M
Cancer Immunol Immunother; 2023 Aug; 72(8):2585-2596. PubMed ID: 37060363
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs.
Perrino M; Voulaz E; Balin S; Cazzato G; Fontana E; Franzese S; Defendi M; De Vincenzo F; Cordua N; Tamma R; Borea F; Aliprandi M; Airoldi M; Cecchi LG; Fazio R; Alloisio M; Marulli G; Santoro A; Di Tommaso L; Ingravallo G; Russo L; Da Rin G; Villa A; Della Bella S; Zucali PA; Mavilio D
Front Immunol; 2024; 15():1288045. PubMed ID: 38629065
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers.
Bartik MM; Baumgartel-Scofield BA; Mokyr MB
Cancer Immunol Immunother; 1991; 34(2):79-89. PubMed ID: 1760820
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice.
Carrio R; Altman NH; Lopez DM
Cancer Immunol Immunother; 2009 Dec; 58(12):2059-72. PubMed ID: 19421751
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Changes in Lymphocyte Populations Establish Zebrafish as a Thymic Involution Model.
Hasan A; Macias JJ; Wood B; Malone-Perez M; Park G; Foster CA; Frazer JK
bioRxiv; 2023 Jul; ():. PubMed ID: 37546788
[TBL] [Abstract][Full Text] [Related]
10. Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells.
Arun I; Wulu JA; Janik JE; Jasper GA; Yuan CM; Venzon D; Stetler-Stevenson M
Cytometry B Clin Cytom; 2010 May; 78(3):169-75. PubMed ID: 20020522
[TBL] [Abstract][Full Text] [Related]
11. The Way Ahead: Lessons Learned from Decades of Cancer Research on Thymomas and Thymic Carcinomas.
Ströbel P; Marx A
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473397
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of primary cutaneus melanoma.
Noveski L; Zhivadinovik J; Matveeva N
Med Pregl; 2014; 67(11-12):392-8. PubMed ID: 25675830
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Correlates of Indoor Tanning and Sunless Tanning Product Use among Female Teens in the United States.
Quinn M; Alamian A; Hillhouse J; Scott C; Turrisi R; Baker K
Prev Med Rep; 2015; 2():40-43. PubMed ID: 25621199
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma of the conjunctiva successful surgical excision of the primary tumor and reconstruction by conjunctival auto transplantation from the contralateral eye.
Sivkova N; Chokoeva AA; Dobrev H; Staribratova D; Belovezhdov V; Tchernev G; Wollina U
Int J Immunopathol Pharmacol; 2014; 27(4):629-34. PubMed ID: 25572743
[TBL] [Abstract][Full Text] [Related]
15. The gamma knife in ophthalmology. Part One--Uveal melanoma.
Wygledowska-Promieńska D; Jurys M; Wilczyński T; Drzyzga Ł
Klin Oczna; 2014; 116(2):130-4. PubMed ID: 25345293
[TBL] [Abstract][Full Text] [Related]
16. Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.
Noguchi S; Kumazaki M; Mori T; Baba K; Okuda M; Mizuno T; Akao Y
Vet Comp Oncol; 2016 Dec; 14(4):384-394. PubMed ID: 25280339
[TBL] [Abstract][Full Text] [Related]
17. Vismodegib in the treatment of advanced BCC.
O'Kane GM; Lyons T; McDonald I; Mulligan N; Moloney FJ; Murray D; Kelly CM
Ir Med J; 2014; 107(7):215-6. PubMed ID: 25226719
[TBL] [Abstract][Full Text] [Related]
18. Completely regressed primary cutaneous melanoma - difficulties in diagnosis and classification.
Mărgăritescu I; Chiriţă AD; Vasilescu F
Rom J Morphol Embryol; 2014; 55(2 Suppl):635-42. PubMed ID: 25178337
[TBL] [Abstract][Full Text] [Related]
19. Prognostic parameters after surgery for adrenal metastases: a single institution experience.
Paunovic I; Zivaljevic V; Diklic A; Tausanovic K; Stojanic R; Sipetic S
Acta Chir Belg; 2014; 114(3):198-202. PubMed ID: 25102710
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
